Table 1 Demographic, clinical and laboratory characteristics of the studied population
Variables | No. (% of N = 1671) |
|---|---|
Age (years), median (interquartile range) | 64.0 (39–80) |
  < 65 | 846 (50.6%) |
  ≥ 65 | 825 (49.4%) |
Gender | Â |
 Female | 784 (46.9%) |
 Male | 887 (53.1%) |
Medical history | |
 Bleeding disorders | 10 (0.6%) |
 Thrombocyte-inhibitors medications | 194 (11.6%) |
 Oral anticoagulant medications | 215 (12.9%) |
 LMW Heparin treatment | 6 (0.4%) |
High-energy trauma (according to ATLS) | 8 (0.5%) |
Clinical presentations | |
 Loss of consciousness | 446 (26.7%) |
 Amnesia | 378 (22.6%) |
 Headache | 388 (23.2%) |
 Worsening headache | 67 (4.0%) |
 Vomiting | 109 (6.5%) |
 Posttraumatic seizures | 20 (1.2%) |
 Alcohol/drug intoxication | 385 (23.0%) |
 Abnormal behavior in emergency department | 59 (3.5%) |
 Signs of depressed/open skull fracture | 115 (6.9%) |
 Signs of basal skull fracture | 213 (12.7%) |
 Signs of facial fracture | 253 (15.1%) |
 Scalp hematoma | 80 (4.8%) |
 Other signs of trauma above the clavicles | 1198 (71.7%) |
 New neurological deficits | 86 (5.1%) |
GCS score | |
  > 13 | 1650 (98.7%) |
  < 14 | 21 (1.3%) |
CT head and spine findings | |
 Intracranial hemorrhage (ICH) | 93 (5.6%) |
 Skull fracture | 54 (3.2%) |
 Facial fracture | 100 (6.0%) |
 Cervical spine fracture | 16 (1.0%) |
Outcomes | |
 Hospital admission | 388 (23.2%) |
 Neurosurgical intervention | 10 (0.6%) |
 Death | 8 (0.5%) |